Latest SEC Filings

Algorhythm Holdings, Inc.Algorhythm Holdings Reports $2.4M in Net Sales, $5.4M Net Loss for Quarter Ending March 31, 2026

Keros Therapeutics, Inc.Keros Therapeutics Reports Significant Revenue Decline and Net Loss in Q1 2026

CorMedix Inc.CorMedix Reports 226% Revenue Growth to $127.4 Million in Latest Quarter

Contango Silver & Gold Inc.Contango Silver & Gold Inc. Reports Significant Asset Growth and Acquisition of Dolly Varden Silver Corporation

Clene Inc.Clene Inc. Reports 81% Revenue Decline and $8.1 Million Net Loss in Q1 2026

Pyxis Oncology, Inc.Pyxis Oncology Reports $23.3 Million Net Loss in Q1 2026, Faces Financial Challenges

CNS Pharmaceuticals, Inc.CNS Pharmaceuticals Reports $4.9 Million Net Loss and Announces New Corporate Strategy

Strive, Inc.Strive, Inc. Reports 94% Revenue Growth to $2.76 Million Amid Increased Operating Expenses

Karyopharm Therapeutics Inc.Karyopharm Therapeutics Reports 17% Revenue Growth to $35.1 Million in Q1 2026

Solo Brands, Inc.Solo Brands Reports 18.6% Decline in Net Sales for Q1 2026

FITLIFE BRANDS, INC.FitLife Brands Reports 59% Revenue Growth to $25.3 Million in Latest Quarter

Wintergreen Acquisition Corp.Wintergreen Acquisition Corp. Reports Q1 2026 Financial Results with Net Income Turnaround

Sunrise Realty Trust, Inc.Sunrise Realty Trust Reports $4.3 Million Net Income in Q1 2026

REGENXBIO Inc.REGENXBIO Reports $90.1 Million Net Loss and Revenue Decline in Latest Quarter

TLGY ACQUISITION CORPTLGY Acquisition Corporation Reports $4.3 Million Net Loss in Q1 2026

Galera Therapeutics, Inc.Galera Therapeutics Reports Q1 2026 Financial Results, Faces Going Concern Risks

Invivyd, Inc.Invivyd Reports $41.4 Million Net Loss in Q1 2026, Revenue Increases to $13.7 Million

Pelthos Therapeutics Inc.Pelthos Therapeutics Reports $10.9M Revenue in Q1 2026, Operating Loss of $13.1M

Chicago Atlantic BDC, Inc.Chicago Atlantic BDC Reports Strong Q1 2026 Financial Performance with $16.7M Investment Income

Cabaletta Bio, Inc.Cabaletta Bio Reports $43.5 Million Net Loss in Q1 2026, Increases R&D Spending

Cellectar Biosciences, Inc.Cellectar Biosciences Reports $5.7M Net Loss and Decreased Operating Expenses for Q1 2026

NIQ Global Intelligence plcNIQ Global Intelligence Reports $1,072.7 Million Revenue in Q1 2026, Net Loss Reduces to $90.1 Million

BK Technologies CorpBK Technologies Reports 11.8% Revenue Growth to $21.3 Million in Q1 2026

WhiteFiber, Inc.WhiteFiber Reports 30.8% Revenue Growth to $21.9 Million in Q1 2026 Despite Net Loss

Aveanna Healthcare Holdings, Inc.Aveanna Healthcare Reports 15.9% Revenue Growth to $647.9 Million